Free Trial
OTC:BBLG

Bone Biologics (BBLG) Stock Price, News & Analysis

Bone Biologics logo
$2.54 -0.10 (-3.79%)
As of 04:00 PM Eastern

About Bone Biologics Stock (OTC:BBLG)

Key Stats

Today's Range
$2.52
$2.73
50-Day Range
$2.54
$6.20
52-Week Range
$2.52
$16.50
Volume
49,763 shs
Average Volume
230,580 shs
Market Capitalization
$1.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BBLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

BBLG Stock News Headlines

BBLG Moves Toward Commercialization
BBLG Splits to Advance
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
Bone Biologics Announces Pricing Of $2 Mln Public Offering
See More Headlines

BBLG Stock Analysis - Frequently Asked Questions

Bone Biologics' stock was trading at $5.6418 at the beginning of the year. Since then, BBLG shares have decreased by 55.0% and is now trading at $2.54.

Bone Biologics Co. (OTC:BBLG) announced its earnings results on Monday, August, 14th. The company reported ($10.14) earnings per share for the quarter, missing the consensus estimate of ($9.00) by $1.14.

Bone Biologics shares reverse split on Tuesday, June 10th 2025.The 1-6 reverse split was announced on Monday, June 9th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 9th 2025. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bone Biologics investors own include Pfizer (PFE), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Advanced Micro Devices (AMD), Canopy Growth (CGC) and Cisco Systems (CSCO).

Company Calendar

Last Earnings
8/14/2023
Today
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTC
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
OTC:BBLG
CIK
1419554
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($49.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-123.44%
Return on Assets
-82.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.95
Quick Ratio
3.95

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.82 per share
Price / Book
1.40

Miscellaneous

Outstanding Shares
545,000
Free Float
2,886,000
Market Cap
$1.38 million
Optionable
Not Optionable
Beta
0.66
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (OTC:BBLG) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners